OGEN
Oragenics Inc
$0.58
-0.01 (-1.69%)
At close · Jul 9
Market Cap
$2.69M
Shares
4,511,957
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$37.65K
-71.4%
FY2023
Net Income
-$984.25M
+6.9%
FY2025
Gross Margin
60.68%
-6.1pp
FY2014
Operating Margin
-55519.89%
-44555.3pp
FY2023
Diluted EPS
-$4.56
+90.5%
FY2025
Operating Cash Flow
-$9.25M
-7.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $37.65K | $131.52K | $86.99K | — | — | — | $0 | $0 | $0 | $939.93K | $1.03M | $1.33M | $1.44M | $1.31M | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $369.6K | $343.35K | $878.46K | $713.63K | $911.79K | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $570.33K | $688.88K | $453.3K | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | 60.68% | 66.74% | 34.04% | — | — | |
| $2.7M | $2.39M | $4.11M | $15.49M | $10.07M | $10.59M | $22.11M | $12.12M | $5.97M | $3.54M | $4.75M | $8.73M | $3.07M | $9.36M | $7.86M | $2.45M | $2.01M | |
| $6.9M | $6.97M | $6.44M | $5.45M | $4.48M | $5.27M | $4.53M | $3.76M | $4.02M | $3.18M | $3.79M | $3.05M | — | — | — | — | — | |
| $3.91M | — | — | — | — | — | — | — | — | — | — | $3.54M | $3.32M | $7.54M | $5.02M | $5.63M | $6.29M | |
| — | — | — | $27.39K | $44.67K | $41.24K | $51.71K | $62.62K | $30.11K | $65.8K | $75.04K | $71.15K | $27.67K | $76.49K | $75.19K | $79.52K | $42.74K | |
| $9.59M | $9.36M | $10.56M | $20.94M | $14.55M | $15.86M | $26.64M | $15.88M | $9.99M | $6.72M | $8.54M | $11.78M | $6.39M | $16.9M | $12.89M | $8.08M | $8.3M | |
| -$9.59M | -$9.36M | -$10.56M | -$20.9M | -$14.42M | -$15.77M | -$26.64M | -$15.88M | -$9.99M | -$6.72M | -$8.54M | -$11.78M | -$5.82M | -$16.21M | -$12.43M | -$7.35M | -$7.9M | |
| — | — | — | -55519.89% | -10964.61% | -18130.32% | — | — | — | — | — | — | -618.82% | -1570.4% | -933.52% | -508.59% | -603.76% | |
| — | — | — | -$20.88M | -$14.38M | -$15.73M | -$26.59M | -$15.81M | -$9.96M | -$6.65M | -$8.47M | -$11.71M | -$5.79M | -$16.13M | -$12.36M | -$7.27M | -$7.86M | |
| $590.53K | $785.93K | $29.83K | $30.59K | $15.1K | $15.76K | $10.69K | $7300 | $5786 | $216.33K | $4116 | $76.67K | $4030 | $17.54K | $655.56K | $332.35K | $33.86K | |
| $212.9K | $182.23K | $45.9K | $210.39K | $135.9K | $75.85K | $89.29K | $320.01K | $86.53K | $10.22K | $40.09K | $21.38K | $37K | $23.55K | $15.16K | $1044 | $3657 | |
| -$394.07K | -$616.89K | -$9103 | $249.17K | $132.38K | $59.4K | $210.76K | $311.57K | $80K | -$13.21K | $45.19K | -$59.21K | $26.98K | $141.48K | -$658.15K | -$332.51K | -$635.93K | |
| — | -$9.98M | -$10.57M | -$20.66M | -$14.29M | -$15.71M | -$26.43M | -$15.57M | -$9.91M | -$6.73M | -$8.5M | -$11.84M | -$5.79M | -$16.07M | -$13.09M | -$7.68M | -$8.54M | |
| — | -$136.91K | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | -$733.44K | |
| -$984.23M | -$984.25M | -$1.06B | -$20.66M | -$14.29M | -$15.71M | -$26.43M | -$15.57M | -$9.91M | -$6.73M | -$7.01M | -$11.71M | -$5.79M | -$16.07M | -$13.09M | -$7.68M | -$7.81M | |
| — | — | — | -54858.14% | -10863.96% | -18062.03% | — | — | — | — | — | — | -615.95% | -1556.7% | -982.94% | -531.61% | -596.31% | |
| — | — | — | — | — | — | — | -$15.57M | -$11.33M | -$6.73M | — | — | — | — | — | — | — | |
| USD/shares | — | -$4.56 | -$47.88 | -$275.40 | -$213.30 | -$242.70 | -$846.00 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$4.56 | -$47.88 | -$275.40 | -$213.30 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 2.16M | 220.73K | 74.99K | 66.97K | 64.77K | 31.41K | 23.49K | 7243.9572 | 2736.8194 | 2478.2961 | 20.36K | 20.09K | 15.99K | 9853.1983 | 3176.4072 | — |
| shares | — | 2.16M | 220.73K | 74.99K | 66.97K | 62.73K | 31.41K | 23.49K | 7243.9572 | 2736.8194 | 2478.2961 | 20.36K | 20.09K | 15.99K | 9853.1983 | 3176.4072 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Biotechnology median 7.68×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Grant | $250,000 | $250,000 | $250,000 |